Georg Holgersson
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Stable longitudinal symptom intensity in cancer patients during end-of-life palliative care at home: prospective cohort study.
Journal: BMJ supportive & palliative care
Published: March 31, 2025
Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer-a retrospective cohort study.
Journal: Translational lung cancer research
Published: September 30, 2024
Regional Perspectives on Complementary and Alternative Medicine: Results of a Regional Survey.
Journal: Complementary medicine research
Published: February 28, 2024
Prospective Study of Preferred Versus Actual Place of Death Among Swedish Palliative Cancer Patients.
Journal: The American journal of hospice & palliative care
Published: November 07, 2023
Use of CAM among cancer patients : Results of a regional survey in Sweden.
Journal: BMC complementary medicine and therapies
Published: November 26, 2022
Geographical Differences in Likelihood of Home Death Among Palliative Cancer Patients: A National Population-based Register Study.
Journal: Anticancer research
Published: June 01, 2020
Socioeconomy as a prognostic factor for location of death in Swedish palliative cancer patients.
Journal: BMC palliative care
Published: May 22, 2020
Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 14, 2018
The role of income in brain tumor patients: a descriptive register-based study : No correlation between patients' income and development of brain cancer.
Journal: Medical oncology (Northwood, London, England)
Published: February 05, 2018
The prognostic value of pre-treatment thrombocytosis in two cohorts of patients with non-small cell lung cancer treated with curatively intended chemoradiotherapy.
Journal: Neoplasma
Published: September 13, 2017
The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: July 04, 2017
Last Updated: 09/26/2026